Global Exosomes Market Size - Forecast to 2026

As per the research conducted by GME, the Exosomes Market is estimated to be valued at USD 1.82 Billion in 2021 and is projected to reach USD 5.58 Billion by 2026 at a CAGR of 25.12%. The expanding preponderance of cancer, technological breakthroughs in exosome isolation & analytical procedures, and enhancing the innovative capabilities of exosomes are among the considerations supporting global exosomes market advancement.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Exosomes Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/exosomes-market-3392

By Workflow (Isolation Methods [Ultracentrifugation, Immunocapture on beads, Precipitation, Filtration], Downstream Analysis [Cell Surface Marker Analysis using Flow Cytometry, Protein analysis using Blotting & ELISA, RNA analysis with NGS & PCR, Proteomic analysis using Mass Spectrometry, Others]), By Biomolecule Type (Non-coding RNAs, mRNA (exoRNA), Proteins /peptides, DNA fragments (exosomal DNA, exoDNA), Lipids), By Application (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Others), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Key Market Insights
• Exosomes play an encouraging role in COVID-19 virus internalization and disease.
• Burgeoning demand for sophisticated technologies aids in the supremacy of the downstream analysis workflow segment.
• The predominance of the Non-coding RNAs segment is foreseen to be driven by the advancement of specialized policies and procedures for non-coding RNA studies.
• The expanding contribution of exosomes to cancer investigation is responsible for the supremacy of the cancer application segment.
• Corporations have endorsed and cooperated with numerous academic institutions which aid in the predominance of North America.
• Takara Bio Company, Illumina, Inc., Thermo Fisher Scientific, Inc., Danaher (Beckman Coulter Inc.), Diagenode Inc., Fujifilm Holdings Corporation, Hitachi Chemical Diagnostics Inc., Lonza, MBL International, Miltenyi Biotec, Novus Biologicals, and Qiagen, among others, are the core players in the market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/exosomes-market-3392

Workflow Outlook (Revenue, USD Billion, 2021-2026)
• Isolation Methods
• Ultracentrifugation
• Immunocapture on beads
• Precipitation
• Filtration
• Downstream Analysis
• Cell Surface Marker Analysis using Flow Cytometry
• Protein analysis using Blotting & ELISA
• RNA analysis with NGS & PCR
• Proteomic analysis using Mass Spectrometry
• Others

Biomolecule Type Outlook (Revenue, USD Billion, 2021-2026)
• Non-coding RNAs
• mRNA (exoRNA)
• Proteins /peptides
• DNA fragments (exosomal DNA, exoDNA)
• Lipids

Application Outlook (Revenue, USD Billion, 2021-2026)
• Cancer
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Others

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: [email protected]
Phone Number: +16026667238
Website: Global Market Estimates
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php